ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Atlanta, GA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Adenocarcinoma
Endometrial Cancer
Recurrence

Prostate Cancer trials near Atlanta, GA, USA:

Study of AZD0754 in Participants With Metastatic Prostate Cancer (APOLLO)

of this study is to evaluate the safety, tolerability, and antitumour activity of AZD0754 CAR T-cell therapy in participants with metastatic prostate...

Enrolling
Metastatic Prostate Cancer
Biological: AZD0754

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Atlanta, Georgia, United States and 11 other locations

Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, pros...

Enrolling
Localized Prostate Cancer
Device: Aquablation Therapy
Procedure: Radical Prostatectomy
PROCEPT BioRobotics

Atlanta, Georgia, United States and 38 other locations

This is a phase 1 study to assess the safety and tolerability of ARX517 as monotherapy or combination therapy in adult subjects with metastatic prostate...

Enrolling
Metastatic Prostate Cancer
Drug: Apalutamide
Drug: Abiraterone acetate

Phase 1

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Atlanta, Georgia, United States and 9 other locations

The purpose of this study is to learn whether PYLARIFY PET imaging (study scan) can safely and accurately detect the presence or absence of prostate...

Enrolling
Prostate Cancer
Drug: Piflufolastat F 18 Intravenous Solution [PYLARIFY]

Phase 4

Lantheus Medical Imaging
Lantheus Medical Imaging

Atlanta, Georgia, United States and 13 other locations

Locations recently updated

with high-risk and very high-risk localised/locally advanced prostate cancer with a breast cancer gene mutation (BRCAm)....

Begins enrollment this month
Prostate Cancer
Drug: Saruparib
Drug: Abiraterone + Prednisolone/Prednisone

Phase 3

AstraZeneca
AstraZeneca

Newnan, Georgia, United States and 145 other locations

Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...

Enrolling
Prostate Cancer
Drug: Abiraterone
Drug: Enzalutamide

Phase 1

Amgen
Amgen

Atlanta, Georgia, United States and 54 other locations

ADT using Degarelix (LHRH antagonist) for men with hormone-sensitive prostate cancer and a rising prostate-specific antige...

Active, not recruiting
Adenocarcinoma of the Prostate
Prostate Cancer
Drug: BMS-986253
Drug: Nivolumab

Phase 1, Phase 2

Mark Stein

Atlanta, Georgia, United States and 3 other locations

injection for biomarker targeted MR molecular imaging (MRMI) of prostate cancer in patients scheduled for radical prostatectomy....

Enrolling
MRI Scan
Drug: MT218 injection

Phase 1, Phase 2

Songqi Gao

Atlanta, Georgia, United States

clinical efficacy in participants with metastatic hormone-sensitive prostate cancer (mHSPC) by progression-free survival.The resear...

Active, not recruiting
Metastatic Hormone-sensitive Prostate Cancer
Other: ADT
Drug: Darolutamide (BAY1841788, Nubeqa)

Phase 2

Bayer
Bayer

Atlanta, Georgia, United States and 31 other locations

plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...

Active, not recruiting
Prostate Cancer
Drug: Placebo
Drug: Prednisone

Phase 2, Phase 3

Lilly
Lilly

Atlanta, Georgia, United States and 112 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems